Skip to main content
Premium Trial:

Request an Annual Quote

Caliper Teams with HistoRx on Protein Biomarkers

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences today said that it has struck an alliance with HistoRx to co-develop new tissue-based imaging and analysis solutions for protein biomarkers.

The collaboration will combine Caliper's Vectra automated, multiplex tissue imaging platform, with HistoRx's Aqua image analysis system. The firms expect the collaboration to advance the identification and validation of new drug targets and improve drug response monitoring.

Under the deal, Caliper will have exclusive worldwide distribution rights for integrated products in the life science research market. The firm also intend to explore collaborative opportunities in clinical research and diagnostics.

"We see an opportunity to bring a comprehensive solution to the research market to help expand scientists' options for capturing key disease signatures and to aid in the development of new drugs and new strategies to battle cancer," Caliper President and CEO Kevin Hrusovsky said in a statement.

Caliper said that it expects an Aqua-enabled Vectra platform to launch in August this year.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.